Ibritumomab Tiuxetan and NovoLog FlexPen
Determining the interaction of Ibritumomab Tiuxetan and NovoLog FlexPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Novolog Injection
- Ibritumomab Tiuxetan-NovoLog Mix 70/30
- Ibritumomab Tiuxetan-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Ibritumomab Tiuxetan-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Ibritumomab Tiuxetan-NovoLog Mix 70/30 FlexPen
- Ibritumomab Tiuxetan-NovoLog PenFill
- NovoLog FlexPen-Ibrutinib
- NovoLog FlexPen-Ibrutinib Capsules
- NovoLog FlexPen-Ibrutinib Tablets
- NovoLog FlexPen-Ibu
- NovoLog FlexPen-IBU Tablets
- NovoLog FlexPen-Ibu-2